Business ❯ Pharmaceutical Industry

Market Dynamics

Pricing Strategies Drug Pricing Drug Sales Drug Pricing Strategies Competition Drug Competition Cost Management Drug Development Export Trends Investment Trends Generic Drugs Product Launch Investment Strategies Stock Performance Drug Costs Stock Market Impact Investor Reactions Pharmacy Benefit Managers Competitiveness Innovation China Vaccine Development Product Safety Export Strategies Import Regulations Sales Volumes Debt Issues Price Increases Sales Performance Patent Expiration Sales Forecasting Supplier Relations Supply Chain Biosimilar Development Anti-Obesity Medications Pricing Issues Tariffs Supply Chain Issues Export Challenges Revenue Generation Drug Approval Process Consumer Access Cancer Therapies Price Control Innovation Strategies U.S. Market Telehealth Services Apothecary Economics Competition Laws Weight Loss Drugs Patents Stock Market Partnerships Drug Demand Competitors Production Costs Investment Eli Lilly Digital Therapeutics Pricing Pressure Regional Market Share Product Protection Strategies Weight Loss Drug Market Pricing Models

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

The once-daily peptide offers biologic-like efficacy without injections.

Analyses Find Limited Savings as TrumpRx Reaches 54 Drugs

Novo Nordisk Licenses Vivtex Platform in $2.1 Billion Push for Oral Obesity and Diabetes Drugs

FDA Expands Addyi Use to Postmenopausal Women, Including Those Over 65

WHO Endorses Long-Term GLP-1 Use for Obesity as Indian Ruling Opens Production and Safety Alerts Expand

Sarepta Shares Plunge After ESSENCE Phase 3 Miss in Duchenne Trial

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

FDA Approves Weekly Leqembi Autoinjector for At-Home Maintenance in Early Alzheimer’s

FDA Flags Possible License Revocation for Sarepta’s Elevidys